The SBS3 signature, which was strongly associated with germline and somatic BRCA1/2 mutations and BRCA1 methylation in other studies, was seen in our study in only two samples; however, both were obtained from BRCA1/2 germline and tumor wild-type patients. Here, BRCA1 is linked to neoplasm.